机译:用抗HB-EGF抗体改性脂质纳米颗粒的SiRNA全身施用用于治疗三重阴性乳腺癌
Department of Medical Biochemistry School of Pharmaceutical Sciences University of Shizuoka 52-1;
Department of Medical Biochemistry School of Pharmaceutical Sciences University of Shizuoka 52-1;
Department of Medical Biochemistry School of Pharmaceutical Sciences University of Shizuoka 52-1;
Department of Medical Biochemistry School of Pharmaceutical Sciences University of Shizuoka 52-1;
Department of Medical Biochemistry School of Pharmaceutical Sciences University of Shizuoka 52-1;
Department of Cardiovascular Medicine Graduate School of Medicine Kagawa University 1750-1;
Department of Medical Biochemistry School of Pharmaceutical Sciences University of Shizuoka 52-1;
antibody; HB-EGF; lipid nanoparticles; siRNA delivery; triple-negative breast cancer;
机译:用抗HB-EGF抗体改性脂质纳米颗粒的SiRNA全身施用用于治疗三重阴性乳腺癌
机译:针对致癌的LNCRNA的肿瘤靶向siRNA纳米颗粒的全身递送促进了有效的三阴性乳腺癌治疗
机译:siRNA纳米粒子为有效的三阴性乳腺癌治疗消除障碍
机译:使用层状纳米颗粒共同递送化学药物和siRNA用于三阴性乳腺癌的治疗
机译:通过LCP纳米颗粒系统递送磷酸化核苷类似物和siRNA,用于癌症治疗。
机译:分层纳米粒子用于抗癌药和潜在的三阴性乳腺癌治疗的siRNA的系统代码传递。
机译:逐层纳米粒子用于抗癌药物的系统编码和用于潜在三阴性乳腺癌治疗的siRNa